Pelvic varicose veins
Varicose veins of atypical location, pelvic congestive syndrome.
Abdominal pain often associated with hormonal changes or heavy legs associated with varicose atypical location (vaginal, vulvar, gluteal hemorrhoids, etc.) Has not received sufficient interest for having overlooked Pelvic venous disease. All these manifestations can relate syndrome ovarian and hypogastric venous insufficiency. Minimally invasive scans can give us accurate diagnosis allows to propose most appropriate therapeutic strategy.


Pelvic congestion syndrome is a frequently misdiagnosed and little known to affect up to 10% of women. It is well known origin and is characterized by the presence of varicose veins ovarian and other veins of the pelvis (hypogastric, pudendal).
Illustration of the distribution of the veins in the pelvic organs
Scheme pelvic venous anatomy

This syndrome can be associated with varicose veins in the legs or can exist in isolation making it difficult to diagnose because there is no external manifestation suspect we can do it. Its main symptom is heaviness or pain in the pelvis or in the female genital area. The pain is of variable intensity that usually does the patient consulted various specialists (gastroenterologists, gynecologists, etc.).

Sometimes, because of the difficulty in diagnosis, these patients have come to consult with the psychiatrist for thinking of psychosomatic pain. Other symptoms include pain during intercourse and urinary discomfort.

The diagnosis is made by minimally invasive studies: transvaginal Doppler ultrasound or magnetic resonance.
Ovarian vein insufficiency
Pelvic venous congestion caused by insufficient left ovarian vein
Varices in ovarian region in patient suffering from pelvic congestive syndrome

It has proven most effective treatment with occlusion or embolization irritants varicose veins. Sometimes it is desirable to combine different strategies that may include the introduction of "coils" or just tiny wires obstructing pathological veins with injection of sclerosing agents such as polidocanol foam.

Dr. Enric Roche
Request information | Back to all news